Literature DB >> 12781023

Rift Valley fever virus infection among French troops in Chad.

Jean Paul Durand, Michèle Bouloy, Laurent Richecoeur, Christophe Nicolas Peyrefitte, Hugues Tolou.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12781023      PMCID: PMC3000143          DOI: 10.3201/eid0906.020647

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: During the rainy season every year, outbreaks of self-limiting nonmalarious febrile syndromes have occurred in French military troops on duty in Chad. To determine the cause of these syndromes, the Tropical Medicine Institute of the French Army Medical Corps implemented an arbovirus surveillance program in Marseille. During summer 2001, we collected samples from 50 soldiers who had a febrile illness. All blood spot samples tested negative by enzyme-linked immunosorbent assay (ELISA) for certain antigens (i.e., dengue virus, West Nile virus, Chikungunya virus, and Wesselsbron virus). However, after co-culture of 31 peripheral blood lymphocyte samples with C6/36 and Vero cell lines collected in NDjamena, Chad, in August to September 2001, two strains of Rift Valley fever virus (RVFV) were isolated and identified by using indirect immunofluorescence with a specific mouse ascitic fluid and by using reverse transcriptase-polymerase chain reaction (RT-PCR) and sequencing. In retrospective testing, we found that all serum specimens tested by ELISA for RVFV-specific immunoglobulin (Ig) M and IgG were negative. The second serum samples from the two case-patients with these strains, collected 2 months later, were strongly positive (IgM 1/200,000; IgG 1/5,000). Rift Valley fever, a febrile disease that affects livestock and humans, is transmitted by mosquitoes and caused by a virus (genus: Phlebovirus, family: Bunyaviridae) that can persist in nature in contaminated eggs. The virus was first isolated in Kenya in 1930 ( ) and is endemic in the region. In Chad, the disease was first reported in 1967 at the same time as in Cameroon ( ); no strain was isolated at that time. Since 1977, RVFV infection resulted in 600 deaths in Egypt ( ), 300 in Mauritania in 1987 ( ), and 200 in Saudi Arabia and Yemen ( , ) in 2000 to 2001. To characterize these RVFV strains, parts of the three genome segments (L, M, and S) were amplified by using RT-PCR and sequenced as described ( , ). The figure shows the phylogenic tree constructed from the sequence of the region coding for NSs in the S segment, by using the neighbor-joining method implemented in Clustal W (version 1.6; available from: URL: http://www-igbmc.u-strasbg.fr/BioInfo/ClustalW/clustalw.html). The two strains identified in Chad are quite similar. They are located within the East/Central lineage established previously ( , ), which contains the virus that circulated in Madagascar (1991), Kenya (1997–1998), and Yemen and Saudi Arabia (2000–2001) ( , ). Sequencing of the region in the M and L segments led to the same clustering (not shown), suggesting that this virus did not evolve by reassortment. Determining the origin of the virus is difficult, but its genetic properties suggest that this strain has a Kenyan origin. Before this isolation, no RVFV strains from Chad had been genetically characterized. This strain may be endemic in this region of Central Africa, or the RVFV strain circulating in the Eastern countries may have been transported outside of the territory (which was likely the case in Yemen and Saudi Arabia in 2000) ( , ). Of the two case-patients, one soldier did not leave NDjamena during his 3-month tour of duty, whereas the other had been in contact with livestock in a flooded area before onset of symptoms. Contamination may have occurred through infected animals or mosquitoes, although sheep living in the area did not show any sign of disease (i.e., spontaneous abortions, deaths). The two cases we describe were self-limiting; however, deaths from this illness have been reported in nonepidemic settings in Central African Republic ( ). Our data emphasize that healthcare providers should systematically consider Rift Valley fever as a diagnosis for febrile syndromes in persons returning from Africa, even in nonepidemic settings ( ).
Figure

NSs-based phylogenetic tree of Rift Valley fever virus strains. Values indicate the bootstrap support of the nodes. Strains isolated in Chad are designated H1CHA01 and H2CHA01, according to the previous abbreviation guidelines (7,8). EMBL accession nos. AJ504997 and AJ504998. SNS, Smithburn strain. Branch lengths are proportional to the number of substitutions per site.

NSs-based phylogenetic tree of Rift Valley fever virus strains. Values indicate the bootstrap support of the nodes. Strains isolated in Chad are designated H1CHA01 and H2CHA01, according to the previous abbreviation guidelines (7,8). EMBL accession nos. AJ504997 and AJ504998. SNS, Smithburn strain. Branch lengths are proportional to the number of substitutions per site.
  11 in total

1.  Genetic reassortment of Rift Valley fever virus in nature.

Authors:  A A Sall; P M Zanotto; O K Sene; H G Zeller; J P Digoutte; Y Thiongane; M Bouloy
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  Outbreak of Rift Valley fever, Yemen, August-October 2000.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2000-12-01

3.  Update: outbreak of Rift Valley Fever--Saudi Arabia, August-November 2000.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2000-11-03       Impact factor: 17.586

4.  [Rift Valley fever: sporadic infection of French military personnel outside currently recognized epidemic zones].

Authors:  J P Durand; L Richecoeur; C Peyrefitte; J P Boutin; B Davoust; H Zeller; M Bouloy; H Tolou
Journal:  Med Trop (Mars)       Date:  2002

5.  An RVF epidemic in southern Mauritania.

Authors:  A Jouan; B Le Guenno; J P Digoutte; B Philippe; O Riou; F Adam
Journal:  Ann Inst Pasteur Virol       Date:  1988 Jul-Sep

6.  [First serologic verification of the incidence of Wesselsbronn's disease and Rift Valley Fever in sheep and wild ruminants in Chad and Cameroon].

Authors:  Y Maurice
Journal:  Rev Elev Med Vet Pays Trop       Date:  1967

7.  Variability of the NS(S) protein among Rift Valley fever virus isolates.

Authors:  A A Sall; P M de A Zanotto; H G Zeller; J P Digoutte; Y Thiongane; M Bouloy
Journal:  J Gen Virol       Date:  1997-11       Impact factor: 3.891

8.  An epizootic of Rift Valley fever in Egypt in 1977.

Authors:  J M Meegan; H Hoogstraal; M I Moussa
Journal:  Vet Rec       Date:  1979-08-11       Impact factor: 2.695

9.  Isolation and genetic characterization of Rift Valley fever virus from Aedes vexans arabiensis, Kingdom of Saudi Arabia.

Authors:  Barry R Miller; Marvin S Godsey; Mary B Crabtree; Harry M Savage; Yagob Al-Mazrao; Mohammed H Al-Jeffri; Abdel-Mohsin M Abdoon; Suleiman M Al-Seghayer; Ali M Al-Shahrani; Thomas G Ksiazek
Journal:  Emerg Infect Dis       Date:  2002-12       Impact factor: 6.883

10.  Genetic analysis of viruses associated with emergence of Rift Valley fever in Saudi Arabia and Yemen, 2000-01.

Authors:  Trevor Shoemaker; Carla Boulianne; Martin J Vincent; Linda Pezzanite; Mohammed M Al-Qahtani; Yagub Al-Mazrou; Ali S Khan; Pierre E Rollin; Robert Swanepoel; Thomas G Ksiazek; Stuart T Nichol
Journal:  Emerg Infect Dis       Date:  2002-12       Impact factor: 6.883

View more
  15 in total

Review 1.  Emerging infectious diseases: the Bunyaviridae.

Authors:  Samantha S Soldan; Francisco González-Scarano
Journal:  J Neurovirol       Date:  2005-10       Impact factor: 2.643

2.  Real-time reverse-transcription loop-mediated isothermal amplification for rapid detection of rift valley Fever virus.

Authors:  Christophe N Peyrefitte; Laetitia Boubis; Daniel Coudrier; Michèle Bouloy; Marc Grandadam; Hugues J Tolou; Sébastien Plumet
Journal:  J Clin Microbiol       Date:  2008-09-17       Impact factor: 5.948

Review 3.  Molecular biology and genetic diversity of Rift Valley fever virus.

Authors:  Tetsuro Ikegami
Journal:  Antiviral Res       Date:  2012-06-16       Impact factor: 5.970

Review 4.  A Historical Review of Military Medical Strategies for Fighting Infectious Diseases: From Battlefields to Global Health.

Authors:  Roberto Biselli; Roberto Nisini; Florigio Lista; Alberto Autore; Marco Lastilla; Giuseppe De Lorenzo; Mario Stefano Peragallo; Tommaso Stroffolini; Raffaele D'Amelio
Journal:  Biomedicines       Date:  2022-08-22

5.  Viral and Bacterial Zoonotic Agents in Dromedary Camels from Southern Tunisia: A Seroprevalence Study.

Authors:  Simone Eckstein; Rosina Ehmann; Abderraouf Gritli; Mohamed Ben Rhaiem; Houcine Ben Yahia; Manuel Diehl; Roman Wölfel; Susann Handrick; Mohamed Ben Moussa; Kilian Stoecker
Journal:  Microorganisms       Date:  2022-03-29

6.  Multiple virus lineages sharing recent common ancestry were associated with a Large Rift Valley fever outbreak among livestock in Kenya during 2006-2007.

Authors:  Brian H Bird; Jane W K Githinji; Joseph M Macharia; Jacqueline L Kasiiti; Rees M Muriithi; Stephen G Gacheru; Joseph O Musaa; Jonathan S Towner; Serena A Reeder; Jennifer B Oliver; Thomas L Stevens; Bobbie R Erickson; Laura T Morgan; Marina L Khristova; Amy L Hartman; James A Comer; Pierre E Rollin; Thomas G Ksiazek; Stuart T Nichol
Journal:  J Virol       Date:  2008-09-10       Impact factor: 5.103

7.  Inter-epidemic acquisition of Rift Valley fever virus in humans in Tanzania.

Authors:  Robert David Sumaye; Emmanuel Nji Abatih; Etienne Thiry; Mbaraka Amuri; Dirk Berkvens; Eveline Geubbels
Journal:  PLoS Negl Trop Dis       Date:  2015-02-27

8.  Rift Valley fever outbreak with East-Central African virus lineage in Mauritania, 2003.

Authors:  Ousmane Faye; Mawlouth Diallo; Djibril Diop; O Elmamy Bezeid; Hampathé Bâ; Mbayame Niang; Ibrahima Dia; Sid Ahmed Ould Mohamed; Kader Ndiaye; Diawo Diallo; Peinda Ogo Ly; Boubacar Diallo; Pierre Nabeth; François Simon; Baïdy Lô; Ousmane Madiagne Diop
Journal:  Emerg Infect Dis       Date:  2007-07       Impact factor: 6.883

9.  Rift Valley fever in Chad.

Authors:  David Ringot; Jean-Paul Durand; Hugues Toulou; Jean-Paul Boutin; Bernard Davoust
Journal:  Emerg Infect Dis       Date:  2004-05       Impact factor: 6.883

10.  A fusion-inhibiting peptide against Rift Valley fever virus inhibits multiple, diverse viruses.

Authors:  Jeffrey W Koehler; Jeffrey M Smith; Daniel R Ripoll; Kristin W Spik; Shannon L Taylor; Catherine V Badger; Rebecca J Grant; Monica M Ogg; Anders Wallqvist; Mary C Guttieri; Robert F Garry; Connie S Schmaljohn
Journal:  PLoS Negl Trop Dis       Date:  2013-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.